BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2318676)

  • 1. Full-length DQ beta cDNA sequences of HLA-DR2/DQw1 subtypes: genetic interactions between two DQ beta loci generate human class II HLA diversity.
    Wu SK; Lu D; Madden M; Liu CP; Miyokawa N; Bach FH; Saunders TL
    Hum Immunol; 1990 Apr; 27(4):305-22. PubMed ID: 2318676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
    Liu CP; Bach FH; Wu SK
    J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cDNA cloning and sequencing reveals that the electrophoretically constant DR beta 2 molecules, as well as the variable DR beta 1 molecules, from HLA-DR2 subtypes have different amino acid sequences including a hypervariable region for a functionally important epitope.
    Wu SK; Yabe T; Madden M; Saunders TL; Bach FH
    J Immunol; 1987 May; 138(9):2953-9. PubMed ID: 3571980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional variability among DQ beta alleles of DR2 subtypes.
    Lee BS; Bell JI; Rust NA; McDevitt HO
    Immunogenetics; 1987; 26(1-2):85-91. PubMed ID: 2886427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DR and DQ beta cDNA sequences associated with a DR2 haplotype.
    Hurley CK; Ziff BL; Steiner N; Gregersen PK; Silver J
    Hum Immunol; 1988 Jul; 22(3):179-83. PubMed ID: 3139589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA restriction fragment length polymorphism of HLA-DR2 haplotypes in normal individuals and in patients with rheumatoid arthritis.
    Singal DP; Reid B; Green D; Bensen WG; D'Souza M
    Ann Rheum Dis; 1990 Mar; 49(3):143-6. PubMed ID: 1969727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein analysis of HLA-DR2.3 haplotype.
    Yabe T; Reinsmoen NL; Wu S; Bach FH
    Hum Immunol; 1987 Jun; 19(2):127-37. PubMed ID: 3497139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing.
    Schreuder GM; van den Berg-Loonen PM; Verduyn W; Geraets DP; Parlevliet J; van Rood JJ; Giphart MJ
    Hum Immunol; 1991 Oct; 32(2):141-9. PubMed ID: 1683866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation.
    Kwok WW; Kovats S; Thurtle P; Nepom GT
    J Immunol; 1993 Mar; 150(6):2263-72. PubMed ID: 8450211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic forms of the alpha- and beta-chain genes encoding DQw1-positive heterodimers.
    Turco E; Care A; Compagnone-Post P; Robinson C; Cascino I; Trucco M
    Immunogenetics; 1987; 26(4-5):282-90. PubMed ID: 2888727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel association of DQ alpha and DQ beta genes in the DRw10 haplotype. Determination of a DQw1 specificity by the DQ beta-chain.
    Merryman P; Silver J; Gregersen PK; Solomon G; Winchester R
    J Immunol; 1989 Sep; 143(6):2068-73. PubMed ID: 2476494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
    Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
    Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters.
    Cohen N; Brautbar C; Font MP; Dausset J; Cohen D
    Immunogenetics; 1986; 23(2):84-9. PubMed ID: 3007344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II sequences of an HLA-DR2 narcoleptic.
    Lock CB; So AK; Welsh KI; Parkes JD; Trowsdale J
    Immunogenetics; 1988; 27(6):449-55. PubMed ID: 3259543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogenotypes defined by short DQ alpha and DQ beta cDNA probes correlate with and define splits of HLA-DQ serological specificities.
    Bidwell JL; Bidwell EA; Laundy GJ; Klouda PT; Bradley BA
    Mol Immunol; 1987 May; 24(5):513-22. PubMed ID: 2889137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequencing of HLA-D in responders and nonresponders to short ragweed allergen, Amb a V.
    Zwollo P; Ehrlich-Kautzky E; Scharf SJ; Ansari AA; Erlich HA; Marsh DG
    Immunogenetics; 1991; 33(2):141-51. PubMed ID: 1999353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR2 subtypes form an additional supertypic family of DR beta alleles.
    Lee BS; Rust NA; McMichael AJ; McDevitt HO
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4591-5. PubMed ID: 2885840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diversity of HLA-DQ. DQ alpha and beta chain isoelectric point differences and their relation to serologically defined HLA-DQ allospecificities.
    Bontrop RE; Baas EJ; Otting N; Schreuder GM; Giphart MJ
    Immunogenetics; 1987; 25(5):305-12. PubMed ID: 3570381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of a subtype of DQw1 recognized by hapten-specific T cells.
    Hanke JH; Cook RG; Leone JW; Van M; Rich RR
    Immunogenetics; 1986; 24(4):209-16. PubMed ID: 2877943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.